Literature DB >> 3603632

The efficacy of meningococcal polysaccharide vaccine in preventing group A meningococcal disease in The Gambia, West Africa.

B M Greenwood, A W Smith, M Hassan-King, H A Bijlmer, F C Shenton, A S Hughes, P P Nunn, A D Jack, P R Gowers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3603632     DOI： 10.1016/0035-9203(86)90303-2

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN： 0035-9203            Impact factor:   2.184


× No keyword cloud information.
  5 in total

1.  Preparedness for infectious threats: public-private partnership to develop an affordable vaccine for an emergent threat: the trivalent Neisseria meningitidis ACW135 polysaccharide vaccine.

Authors:  Christopher B Nelson; Maureen Birmingham; Alejandro Costa; Joelle Daviaud; William Perea; Marie-Paule Kieny; Daniel Tarantola
Journal:  Am J Public Health       Date:  2007-04-05       Impact factor: 9.308

2.  Measurement of functional anti-meningococcal serogroup a activity using strain 3125 as the target strain for serum bactericidal assay.

Authors:  Jan T Poolman; Isabel De Vleeschauwer; Nathalie Durant; Nathalie Devos; Christiane Feron; Pascal Lestrate; Vincent Weynants; Dominique Boutriau
Journal:  Clin Vaccine Immunol       Date:  2011-05-18

Review 3.  Meningococcal vaccines. Current status and future possibilities.

Authors:  H Peltola
Journal:  Drugs       Date:  1998-03       Impact factor: 9.546

4.  Recent increase in meningitis Caused by Neisseria meningitidis serogroups A and W135, Yaoundé, Cameroon.

Authors:  Marie-Christine Fonkoua; Muhamed-Kheir Taha; Pierre Nicolas; Patrick Cunin; Jean-Michel Alonso; Raymond Bercion; Jeanne Musi; Paul M V Martin
Journal:  Emerg Infect Dis       Date:  2002-03       Impact factor: 6.883

5.  A phase II, randomized study on an investigational DTPw-HBV/Hib-MenAC conjugate vaccine administered to infants in Northern Ghana.

Authors:  Abraham Hodgson; Abudulai Adams Forgor; Daniel Chandramohan; Zarifah Reed; Fred Binka; Cornelia Bevilacqua; Dominique Boutriau; Brian Greenwood
Journal:  PLoS One       Date:  2008-05-14       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.